Medpace reduces revolving credit facility from $150M to $10M, extends to March 2025

Medpace Holdings, Inc.

Line of credit reduced to $10M from $150M; expiration extended to March 31, 2025.
Amendment adds new compliance representations on anti-corruption, trade sanctions, and anti-money laundering.
Facility remains unsecured; borrower Medpace Inc. and guarantor Medpace IntermediateCo.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Medpace Holdings, Inc. amended Amendment No. 6 to Loan Documents with PNC Bank, National Association valued at up to $10 million (effective 2024-03-28).

Action: amendment
Agreement: credit facility
Counterparty: PNC Bank, National Association
Value: up to $10 million
Effective: 2024-03-28

Exact text from the filing

Medpace Holdings, Inc., a Delaware corporation (the "Company"), through its wholly owned subsidiaries, Medpace, Inc., as borrower, and Medpace IntermediateCo, Inc., as guarantor, entered into Amendment No. 6 to Loan Documents (“Amendment No. 6”) with PNC Bank, National Association

View on SEC.gov

291 material agreements filed in the last 30 days. Browse all material agreements →

Medpace Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001668397-24-000066

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.